| Product Code: ETC12463536 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Togo continued to rely on key countries such as France, India, China, USA, and Denmark for its import shipments of Imatinib drugs. Despite a high level of market concentration indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -2.47%. Furthermore, the growth rate from 2023 to 2024 decreased by -8.58%, pointing to a challenging market environment for Imatinib imports in Togo.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Imatinib Drug Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Togo Imatinib Drug Market - Industry Life Cycle |
3.4 Togo Imatinib Drug Market - Porter's Five Forces |
3.5 Togo Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Togo Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Togo Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Togo Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Togo Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Togo Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Togo |
4.2.2 Growing awareness about the effectiveness of imatinib drug in treating certain types of cancer |
4.2.3 Favorable government initiatives to improve access to essential medicines |
4.3 Market Restraints |
4.3.1 High cost of imatinib drug leading to affordability issues for patients |
4.3.2 Limited healthcare infrastructure and resources in Togo affecting distribution and availability of the drug |
5 Togo Imatinib Drug Market Trends |
6 Togo Imatinib Drug Market, By Types |
6.1 Togo Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Togo Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Togo Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Togo Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Togo Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Togo Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Togo Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Togo Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Togo Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Togo Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Togo Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Togo Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Togo Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Togo Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Togo Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Togo Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Togo Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Togo Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Togo Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Togo Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Togo Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Togo Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Togo Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Togo Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Togo Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Togo Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Togo Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Togo Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Togo Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Togo Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Togo Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Togo Imatinib Drug Market Import-Export Trade Statistics |
7.1 Togo Imatinib Drug Market Export to Major Countries |
7.2 Togo Imatinib Drug Market Imports from Major Countries |
8 Togo Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib treatment |
8.2 Number of oncologists prescribing imatinib in Togo |
8.3 Rate of successful outcomes in cancer treatment with imatinib |
8.4 Level of government support for subsidizing imatinib drug prices |
8.5 Availability and accessibility of imatinib drug in different regions of Togo |
9 Togo Imatinib Drug Market - Opportunity Assessment |
9.1 Togo Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Togo Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Togo Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Togo Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Togo Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Togo Imatinib Drug Market - Competitive Landscape |
10.1 Togo Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Togo Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |